Science
DeepBAR: AI-Based Technique That May Speed Drug Discovery – Genetic Engineering & Biotechnology News
DeepBAR is a new technique that combines chemistry and machine learning to speed up calculations of drug molecules’ binding affinity to proteins.
A new technique, DeepBAR, quickly calculates the binding affinities between drug candidates and their targets. The approach, which combines chemistry and machine learning, could lower a hurdle in the drug discovery process. DeepBAR yields precise calculations in a fraction of the time compared to previous state-of-the-art methods. The inventors say DeepBAR could one day quicken the pace of drug discovery and protein engineering.
“Our method is orders of magnitude faster than before, meaning we can…
Continue Reading